Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development

被引:0
|
作者
Rajakishore Mishra
Bibhu Ranjan Das
机构
[1] Institute of Life Sciences,Molecular Oncology and Medical Biotechnology Division
[2] Nalco Square,undefined
[3] Chandrasekharpur,undefined
来源
Molecular Biology Reports | 2003年 / 30卷
关键词
Cdk4; c-myc; KRF; oral cancer; transcription factor;
D O I
暂无
中图分类号
学科分类号
摘要
Cyclin Dependent Kinase 4 (Cdk4) is known to be an oncogene and is involved in various cancers. It is overexpressed either by genomic amplification or by c-myc dependent manner. Our preliminary results indicate high expression of protein and mRNA as well as absence of genomic amplification in early oral cancer development. One transcription factor (TF) binding site has been detected from −281 to −298 by using DNase I foot printing and confirmed by electrophoretic mobility shift assay. This is a novel DNA sequence. The recruitment of this new TF as well as the earlier reported c-myc was analyzed in various stage of oral cancer development. The binding activity of the new TF is present in normal tissues and observed more in initial stage samples whereas c-myc expression was absent in normal and more in higher stage of oral cancer development. On the basis of these findings we propose the new TF to be a possible CdK4 Regulating Factor (KRF). This might maintain the basal level transcription in normal and activates Cdk4 transcription in the initial stage, where as the same role is carried by c-myc in higher stage of chewing tobacco mediated oral cancer development.
引用
收藏
页码:207 / 213
页数:6
相关论文
共 50 条
  • [1] Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development
    Mishra, R
    Das, BR
    MOLECULAR BIOLOGY REPORTS, 2003, 30 (04) : 207 - 213
  • [2] Identification of CDK4 as a target of c-MYC
    Hermeking, H
    Rago, C
    Schuhmacher, M
    Li, Q
    Barrett, JF
    Obaya, AJ
    O'Connell, BC
    Mateyak, MK
    Tam, W
    Kohlhuber, F
    Dang, CV
    Sedivy, JM
    Eick, D
    Vogelstein, B
    Kinzler, KW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) : 2229 - 2234
  • [3] c-MYC mediated resistance to trametinib plus hydroxychloroquine in pancreatic cancer is overcome by CDK4/6 and lysosomal inhibition
    Silvis, Mark
    Silva, Dilru
    Riley, Rohweder
    Schuman, Sophia
    Gudipaty, Swapna
    Truong, Amanda
    Yap, Jeffery
    Affolter, Kajsa
    McMahon, Martin
    Kinsey, Conan
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc
    Snehalata A Pawar
    Marilyn N Szentirmay
    Heiko Hermeking
    Michèle Sawadogo
    Oncogene, 2004, 23 : 6125 - 6135
  • [5] Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc
    Pawar, SA
    Szentirmay, MN
    Hermeking, H
    Sawadogo, M
    ONCOGENE, 2004, 23 (36) : 6125 - 6135
  • [6] The role of CDK4/6 inhibitors in early breast cancer
    Gil-Gil, Miguel
    Alba, Emilio
    Gavila, Joaquin
    de la Haba-Rodriguez, Juan
    Ciruelos, Eva
    Tolosa, Pablo
    Candini, Daniele
    Llombart-Cussac, Antonio
    BREAST, 2021, 58 : 160 - 169
  • [7] ROLE OF C-MYC PROTEIN IN THE EARLY EMBRYONIC-DEVELOPMENT
    MECHALI, M
    EVAN, G
    GUSSE, M
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1989, 308 (08): : 213 - 218
  • [8] The c-Myc targeting hnRNPAB promotes lung adenocarcinoma cell proliferation via stabilization of CDK4 mRNA
    Xu, Chen
    Li, Bingyan
    Yu, Ning
    Yao, Bo
    Wang, Fang
    Mei, Yide
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 156
  • [9] THE ROLE OF C-MYC ONCOGENE EXPRESSION IN THE DEVELOPMENT OF GASTRIC-CANCER
    MACDONALD, F
    ALLUM, WH
    STOKES, H
    RUSSELL, B
    FIELDING, JWL
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 544 - 545
  • [10] Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer
    Kim, Sungsoo
    Armand, Jessica
    Safonov, Anton
    Zhang, Mimi
    Soni, Rajesh K.
    Schwartz, Gary
    McGuinness, Julia E.
    Hibshoosh, Hanina
    Razavi, Pedram
    Kim, Minah
    Chandarlapaty, Sarat
    Yang, Hee Won
    CELL REPORTS, 2023, 42 (11):